This post was originally published on this site
https://i-invdn-com.investing.com/news/LYNXNPEC3B0CQ_M.jpg
Ginkgo Bioworks (DNA) 23% HIGHER; reported Q2 EPS of ($0.41), $0.36 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $145 million versus the consensus estimate of $78.83 million. Ginkgo Bioworks sees FY2022 revenue of $425-440 million, versus the consensus of $393 million.
Fabrinet (NYSE:FN) 12% HIGHER; reported Q4 EPS of $1.68, $0.14 better than the analyst estimate of $1.54. Revenue for the quarter came in at $587.9 million versus the consensus estimate of $581.48 million. Fabrinet sees Q1 2023 EPS of $1.72-$1.79, versus the consensus of $1.56. Fabrinet sees Q1 2023 revenue of $620-640 million, versus the consensus of $596 million.
Compass (COMP) 11% LOWER; reported Q2 EPS of ($0.24), $0.07 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $2 billion versus the consensus estimate of $2.11 billion. Compass sees FY2022 revenue of $6.15-6.45 billion, versus the consensus of $7.6 billion.
ZipRecruiter (ZIP) 5% LOWER; reported Q2 EPS of $0.11, $0.05 better than the analyst estimate of $0.06. Revenue for the quarter came in at $239.9 million versus the consensus estimate of $233.83 million. ZipRecruiter raises Q3 2022 revenue to $217-223 million, versus the consensus of $233.6 million. ZipRecruiter raises FY2022 revenue to $883-897 million, versus the consensus of $914.6 million.
